OP Pharma has been delivering customized Regulatory Affairs services for over 20 years to pharmaceutical companies in the European Union. The services range from submission and monitoring of various practices to technical documentation including lifecycle management and eCTD compliance. With internally developed IT tools, OP Pharma efficiently manages regulatory affairs data for numerous products. Additionally, OP Pharma has a track record of developing and registering innovative pharmaceutical products, such as topical Diclofenac 4%, Dexibuprofen, and generic liquid Vit D3, with successful registrations across multiple EU countries. OP Pharma is interested in collaborating with local partners worldwide to promote and distribute their products through mutually beneficial partnerships.
O.P. Pharma
Headquarters
Italy